# Effect of Prebiotics and/or Probiotics on Uremic Toxins and Inflammation Markers in Peritoneal Dialysis Patients

> **NCT03770611** · NA · UNKNOWN · sponsor: **Unidad de Investigacion Medica en Enfermedades Renales** · enrollment: 112 (estimated)

## Conditions studied

- End Stage Renal Failure on Dialysis

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic
- **DIETARY_SUPPLEMENT:** Prebiotic
- **DIETARY_SUPPLEMENT:** Symbiotic
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03770611
- **Lead sponsor:** Unidad de Investigacion Medica en Enfermedades Renales
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-07
- **Primary completion:** 2019-12
- **Final completion:** 2020-08
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2018-12-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03770611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03770611, "Effect of Prebiotics and/or Probiotics on Uremic Toxins and Inflammation Markers in Peritoneal Dialysis Patients". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT03770611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*